206 related articles for article (PubMed ID: 18033314)
41. EPHA4 is overexpressed but not functionally active in Sézary syndrome.
Hameetman L; van der Fits L; Zoutman WH; Out-Luiting JJ; Siegal G; de Esch IJ; Vermeer MH; Tensen CP
Oncotarget; 2015 Oct; 6(31):31868-76. PubMed ID: 26376612
[TBL] [Abstract][Full Text] [Related]
42. Promoter-Specific Hypomethylation Is Associated with Overexpression of PLS3, GATA6, and TWIST1 in the Sezary Syndrome.
Wong HK; Gibson H; Hake T; Geyer S; Frederickson J; Marcucci G; Caligiuri MA; Porcu P; Mishra A
J Invest Dermatol; 2015 Aug; 135(8):2084-2092. PubMed ID: 25806852
[TBL] [Abstract][Full Text] [Related]
43. Independent Loss of Methylthioadenosine Phosphorylase (MTAP) in Primary Cutaneous T-Cell Lymphoma.
Woollard WJ; Kalaivani NP; Jones CL; Roper C; Tung L; Lee JJ; Thomas BR; Tosi I; Ferreira S; Beyers CZ; McKenzie RCT; Butler RM; Lorenc A; Whittaker SJ; Mitchell TJ
J Invest Dermatol; 2016 Jun; 136(6):1238-1246. PubMed ID: 26872600
[TBL] [Abstract][Full Text] [Related]
44. Sézary Syndrome: Clinical and Biological Aspects.
Kohnken R; Fabbro S; Hastings J; Porcu P; Mishra A
Curr Hematol Malig Rep; 2016 Dec; 11(6):468-479. PubMed ID: 27704468
[TBL] [Abstract][Full Text] [Related]
45. Hypomethylation of the promoter region drives ectopic expression of TMEM244 in Sézary cells.
Iżykowska K; Rassek K; Żurawek M; Nowicka K; Paczkowska J; Ziółkowska-Suchanek I; Podralska M; Dzikiewicz-Krawczyk A; Joks M; Olek-Hrab K; Giefing M; Przybylski GK
J Cell Mol Med; 2020 Sep; 24(18):10970-10977. PubMed ID: 32794659
[TBL] [Abstract][Full Text] [Related]
46. The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome.
da Silva Almeida AC; Abate F; Khiabanian H; Martinez-Escala E; Guitart J; Tensen CP; Vermeer MH; Rabadan R; Ferrando A; Palomero T
Nat Genet; 2015 Dec; 47(12):1465-70. PubMed ID: 26551667
[TBL] [Abstract][Full Text] [Related]
47. Identification of tyrosine kinase, HCK, and tumor suppressor, BIN1, as potential mediators of AHI-1 oncogene in primary and transformed CTCL cells.
Kennah E; Ringrose A; Zhou LL; Esmailzadeh S; Qian H; Su MW; Zhou Y; Jiang X
Blood; 2009 May; 113(19):4646-55. PubMed ID: 19211505
[TBL] [Abstract][Full Text] [Related]
48. The antihistamines clemastine and desloratadine inhibit STAT3 and c-Myc activities and induce apoptosis in cutaneous T-cell lymphoma cell lines.
Döbbeling U; Waeckerle-Men Y; Zabel F; Graf N; Kündig TM; Johansen P
Exp Dermatol; 2013 Feb; 22(2):119-24. PubMed ID: 23362870
[TBL] [Abstract][Full Text] [Related]
49. Human Endogenous Retrovirus Expression in Primary Cutaneous T-Cell Lymphomas.
Fava P; Bergallo M; Astrua C; Brizio M; Galliano I; Montanari P; Tovo PA; Novelli M; Savoia P; Quaglino P; Fierro MT
Dermatology; 2016; 232(1):38-43. PubMed ID: 26580164
[TBL] [Abstract][Full Text] [Related]
50. Genome-wide transcriptome analysis of the STAT6-regulated genes in advanced-stage cutaneous T-cell lymphoma.
Gaydosik AM; Queen DS; Trager MH; Akilov OE; Geskin LJ; Fuschiotti P
Blood; 2020 Oct; 136(15):1748-1759. PubMed ID: 32438399
[TBL] [Abstract][Full Text] [Related]
51. The Use of Transcriptional Profiling to Improve Personalized Diagnosis and Management of Cutaneous T-cell Lymphoma (CTCL).
Litvinov IV; Netchiporouk E; Cordeiro B; Doré MA; Moreau L; Pehr K; Gilbert M; Zhou Y; Sasseville D; Kupper TS
Clin Cancer Res; 2015 Jun; 21(12):2820-9. PubMed ID: 25779945
[TBL] [Abstract][Full Text] [Related]
52. CD158k is a reliable marker for diagnosis of Sézary syndrome and reveals an unprecedented heterogeneity of circulating malignant cells.
Moins-Teisserenc H; Daubord M; Clave E; Douay C; Félix J; Marie-Cardine A; Ram-Wolff C; Maki G; Beldjord K; Homyrda L; Michel L; Bensussan A; Toubert A; Bagot M
J Invest Dermatol; 2015 Jan; 135(1):247-257. PubMed ID: 25158034
[TBL] [Abstract][Full Text] [Related]
53. Molecular profiling of TOX-deficient neoplastic cells in cutaneous T cell lymphoma.
Xu J; Huang H; Wang S; Chen Y; Yin X; Zhang X; Zhang Y
Arch Dermatol Res; 2020 Sep; 312(7):513-525. PubMed ID: 31676945
[TBL] [Abstract][Full Text] [Related]
54. Induced Sézary syndrome PBMCs poorly express immune response genes up-regulated in stimulated memory T cells.
Chong BF; Dantzer P; Germeroth T; Hafner M; Wilson AJ; Xiao G; Wong HK
J Dermatol Sci; 2010 Oct; 60(1):8-20. PubMed ID: 20801618
[TBL] [Abstract][Full Text] [Related]
55. STAT5 induces miR-21 expression in cutaneous T cell lymphoma.
Lindahl LM; Fredholm S; Joseph C; Nielsen BS; Jønson L; Willerslev-Olsen A; Gluud M; Blümel E; Petersen DL; Sibbesen N; Hu T; Nastasi C; Krejsgaard T; Jæhger D; Persson JL; Mongan N; Wasik MA; Litvinov IV; Sasseville D; Koralov SB; Bonefeld CM; Geisler C; Woetmann A; Ralfkiaer E; Iversen L; Odum N
Oncotarget; 2016 Jul; 7(29):45730-45744. PubMed ID: 27329723
[TBL] [Abstract][Full Text] [Related]
56. Diagnostic and prognostic importance of T-cell receptor gene analysis in patients with Sézary syndrome.
Fraser-Andrews EA; Russell-Jones R; Woolford AJ; Wolstencroft RA; Dean AJ; Whittaker SJ
Cancer; 2001 Oct; 92(7):1745-52. PubMed ID: 11745245
[TBL] [Abstract][Full Text] [Related]
57. MicroRNA-181 contributes to downregulation of SAMHD1 expression in CD4+ T-cells derived from Sèzary syndrome patients.
Kohnken R; Kodigepalli KM; Mishra A; Porcu P; Wu L
Leuk Res; 2017 Jan; 52():58-66. PubMed ID: 27889686
[TBL] [Abstract][Full Text] [Related]
58. Downregulation of Fas gene expression in Sézary syndrome is associated with promoter hypermethylation.
Jones CL; Wain EM; Chu CC; Tosi I; Foster R; McKenzie RC; Whittaker SJ; Mitchell TJ
J Invest Dermatol; 2010 Apr; 130(4):1116-25. PubMed ID: 19759548
[TBL] [Abstract][Full Text] [Related]
59. Genetic rearrangements result in altered gene expression and novel fusion transcripts in Sézary syndrome.
Iżykowska K; Przybylski GK; Gand C; Braun FC; Grabarczyk P; Kuss AW; Olek-Hrab K; Bastidas Torres AN; Vermeer MH; Zoutman WH; Tensen CP; Schmidt CA
Oncotarget; 2017 Jun; 8(24):39627-39639. PubMed ID: 28489605
[TBL] [Abstract][Full Text] [Related]
60. Cutaneous tumor cell load correlates with survival in patients with Sézary syndrome.
Booken N; Nicolay JP; Weiss C; Klemke CD
J Dtsch Dermatol Ges; 2013 Jan; 11(1):67-79. PubMed ID: 23167557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
